You are viewing a free preview of this lesson.
Subscribe to unlock all 10 lessons in this course and every other course on LearningBro.
The specific (adaptive) immune response is activated when pathogens breach the non-specific defences. It involves lymphocytes — B cells and T cells — that recognise specific antigens and mount a targeted response. This lesson covers the roles of B cells and T cells, antigen presentation, clonal selection, and the cell-mediated and humoral immune responses for the Edexcel A-Level Biology (9BI0) specification.
An antigen is any molecule (usually a protein or glycoprotein) that is recognised by the immune system and can trigger an immune response.
| Type | Description | Example |
|---|---|---|
| Foreign antigens | Molecules on the surface of pathogens, toxins, or foreign cells | Bacterial cell wall proteins, viral capsid proteins, pollen proteins |
| Self-antigens | Molecules on the surface of the body's own cells | MHC (Major Histocompatibility Complex) proteins — unique to each individual |
Both B cells and T cells are produced from stem cells in the bone marrow but mature in different locations:
| Feature | B cells | T cells |
|---|---|---|
| Maturation site | Bone marrow | Thymus |
| Receptors | B cell receptors (BCRs) — membrane-bound antibodies | T cell receptors (TCRs) |
| Function | Produce antibodies (humoral immunity) | Cell-mediated immunity (kill infected cells, activate B cells) |
| Antigen recognition | Can recognise free antigens directly | Recognise antigens only when presented on MHC proteins by APCs |
The body produces millions of different B cells and T cells, each with a unique receptor that recognises one specific antigen. This diversity is generated by genetic recombination during lymphocyte development.
When a pathogen enters the body:
Exam Tip: Clonal selection is a key concept. Each lymphocyte is specific to one antigen. Out of millions of lymphocytes, only those with the correct receptor are activated. This explains why the primary immune response takes several days — the correct clone must be found, expanded, and differentiated.
T cells are central to the cell-mediated response. They are activated when an antigen-presenting cell (APC) — typically a macrophage or dendritic cell — presents a processed antigen on its MHC class II protein.
| T cell type | Function |
|---|---|
| T helper cells (Th, CD4⁺) | Recognise antigen-MHC II complexes on APCs. Release cytokines that: activate B cells (humoral response), activate cytotoxic T cells, enhance phagocyte activity |
| Cytotoxic T cells (Tc, CD8⁺) | Recognise antigen-MHC I complexes on infected body cells. Kill infected cells by releasing perforin (forms pores) and granzymes (trigger apoptosis) |
| Regulatory T cells (Treg) | Suppress the immune response after the pathogen has been cleared; prevent autoimmunity |
| Memory T cells | Long-lived cells that persist after infection; provide rapid secondary response upon re-exposure |
Exam Tip: HIV attacks T helper cells (CD4⁺), which explains why it is so devastating — without T helper cells, neither the cell-mediated nor the humoral immune response can be properly activated.
The humoral response involves B cells producing antibodies that circulate in the blood and body fluids (humour = fluid).
The following diagram summarises the humoral immune response from antigen recognition to antibody action:
graph TD
A["Antigen binds to<br/>B cell receptor"] --> B["B cell activated<br/>(+ helper T cell)"]
B --> C["Clonal Expansion"]
C --> D["Plasma Cells<br/>(secrete antibodies)"]
C --> E["Memory B Cells<br/>(long-lived)"]
D --> F["Antibodies bind<br/>to antigens"]
F --> G["Agglutination /<br/>Neutralisation"]
Most B cells require T helper cell activation to fully differentiate. This is called T-dependent activation and is the most common pathway for protein antigens.
Some antigens (e.g. polysaccharide antigens) can activate B cells without T cell help (T-independent activation), but this produces a weaker response with limited memory.
| Feature | Primary response | Secondary response |
|---|---|---|
| Timing | Slow (7–14 days to peak) | Rapid (1–3 days to peak) |
| Antibody levels | Lower peak | Much higher peak |
| Main antibody | IgM (initial), then IgG | Predominantly IgG |
| Cells involved | Naive B and T cells | Memory B and T cells |
| Why faster? | N/A | Memory cells are already present in large numbers; they recognise the antigen immediately and undergo rapid clonal expansion |
The secondary response is the basis of vaccination and explains why you rarely get the same disease twice.
| MHC type | Found on | Presents antigens to | Function |
|---|---|---|---|
| MHC class I | All nucleated body cells | Cytotoxic T cells (CD8⁺) | Displays intracellular antigens (e.g. viral proteins produced inside the cell) |
| MHC class II | APCs only (macrophages, dendritic cells, B cells) | T helper cells (CD4⁺) | Displays extracellular antigens that have been phagocytosed and processed |
Exam Tip: MHC I is on all nucleated cells (not red blood cells, which lack a nucleus). MHC II is only on antigen-presenting cells. This distinction is important for explaining which T cells respond and why.
| Term | Definition |
|---|---|
| Antigen | A molecule (usually a protein) that triggers a specific immune response |
| Clonal selection | The activation of a specific lymphocyte whose receptor matches the invading antigen |
| Clonal expansion | The rapid division (mitosis) of an activated lymphocyte to form a clone |
| Plasma cell | An effector B cell that secretes antibodies at a high rate |
| Memory cell | A long-lived lymphocyte that enables a faster, stronger secondary response |
| Cytokine | A signalling protein released by immune cells that regulates immune responses |
| Apoptosis | Programmed cell death, triggered by cytotoxic T cells or granzymes |
The Edexcel 9BI0 specification places the specific (adaptive) immune response within Topic 6: Immunity, Infection and Forensics, between the innate response and antibodies/vaccination. Lesson 6 (innate immunity) ended with MHC class II antigen presentation — the molecular handover that opens this lesson. Lesson 8 (antibodies) unpacks the antibody structure and effector mechanisms (opsonisation, agglutination, complement activation) downstream of the plasma cells generated here. Lesson 9 (vaccination) exploits the memory-cell component to drive priming without live pathogen exposure. Synoptic links extend to Topic 1 (antibody quaternary structure: two heavy + two light chains, hinge region, Fab and Fc split) and Topic 8 (receptor diversity from V(D)J recombination; autoimmune disease as failure of central tolerance). Relevant statements concern lymphocyte development, MHC-restricted antigen presentation, clonal selection and expansion, the cell-mediated and humoral arms, primary and secondary responses and immunological memory (refer to the official Pearson Edexcel 9BI0 specification document for exact wording).
Question (8 marks):
A child is exposed to Bordetella pertussis (whooping cough) for the first time. The bacterium is engulfed by a respiratory dendritic cell, and within ten days the child develops detectable serum antibodies and a cytotoxic T-cell response.
(a) Describe the cascade by which dendritic-cell antigen presentation activates a T helper cell, including the two-signal rule that prevents accidental activation. (4)
(b) Explain how the activated T helper cell drives the parallel humoral and cell-mediated arms, and account for the ten-day delay. (4)
Solution with mark scheme:
(a) Stage 1 — antigen processing and MHC II loading. The dendritic cell phagocytoses B. pertussis, lysosomal proteases cleave bacterial proteins into peptide fragments (~12–25 aa), and peptides are loaded onto MHC class II in an endosomal compartment, then trafficked to the surface.
M1 (AO1.1) — peptide loaded onto MHC class II, displayed at surface.
Stage 2 — TCR–MHC engagement (signal one). A naive CD4+ T helper with a complementary TCR binds the MHC II–peptide complex; the CD4 co-receptor stabilises the contact.
M1 (AO1.2) — TCR–MHC II engagement with CD4 stabilisation.
Stage 3 — co-stimulation (signal two). PRR engagement on the dendritic cell upregulates B7 (CD80/CD86), which binds CD28 on the T helper. Both signals required.
M1 (AO1.2) — CD28–B7 co-stimulation; the two-signal rule prevents accidental self-activation (signal one alone induces anergy).
Stage 4 — clonal expansion. Activated helpers upregulate IL-2 and IL-2 receptor; autocrine signalling drives proliferation; daughter clones differentiate into Th1, Th2 and memory subsets.
A1 (AO3.1a) — IL-2-driven autocrine proliferation; Th1/Th2/memory differentiation.
(b) M1 (AO2.1) — Humoral arm. Th2-polarised helpers release IL-4, IL-5, IL-6 that stimulate a B cell whose BCR has bound B. pertussis antigen. The B cell re-presents the same antigen on MHC II, the T helper recognises it (linked recognition), and the B cell undergoes clonal expansion into plasma cells and memory B cells.
M1 (AO2.1) — Cell-mediated arm. Th1-polarised helpers secrete IL-2 and IFN-γ that drive CD8+ cytotoxic T-cell proliferation. CTLs recognise B. pertussis peptides on MHC class I of infected epithelial cells and kill them by perforin/granzyme apoptosis.
M1 (AO1.2) — naming perforin and granzymes on the cell-mediated side; plasma cells and memory B cells on the humoral side.
A1 (AO3.1a) — the ten-day delay reflects clonal selection mathematics: ~1 in 106 naive lymphocytes match any antigen; that rare clone must be located, two-signal-activated and undergo ~10–15 rounds of mitosis. Slowness is the price of specificity — and exactly the lag vaccination abolishes by pre-establishing memory clones.
Total: 8 marks.
Question (6 marks): Compare and contrast the activation, effector mechanisms and final targets of CD4+ T helper cells and CD8+ cytotoxic T cells, and explain why HIV infection of CD4+ cells collapses both arms of adaptive immunity.
Mark scheme decomposition by AO:
| Marking point | AO | Credit-worthy content |
|---|---|---|
| 1 | AO1.1 | States that CD4+ T helper cells recognise antigen on MHC class II displayed by professional APCs (macrophages, dendritic cells, B cells), require two-signal activation (TCR–MHC II + CD28–B7), and act by secreting cytokines (IL-2, IL-4, IL-6, IFN-γ) that orchestrate other immune cells. |
| 2 | AO1.2 | States that CD8+ cytotoxic T cells recognise antigen on MHC class I (present on all nucleated cells), are licensed by Th-derived IL-2, and kill infected target cells directly via perforin (pore formation) and granzymes (caspase-mediated apoptosis). |
| 3 | AO2.1 | Contrasts the targets: T helpers act on immune cells (B cells, cytotoxic T cells, macrophages) — they coordinate; cytotoxic T cells act on any infected nucleated cell — they execute. T helpers do not kill; cytotoxic T cells do not coordinate. |
| 4 | AO2.1 | Explains MHC-class targeting logic: MHC II presents extracellular antigens (engulfed by APCs) to CD4+ helpers; MHC I presents intracellular antigens (synthesised inside any cell, e.g. viral proteins) to CD8+ killers. The two classes report on different compartments. |
| 5 | AO3.1a | Explains the HIV paradox: depleting CD4+ T helpers simultaneously cripples the humoral arm (B cells lose linked-recognition cytokine help, cannot class-switch fully to IgG) and the cell-mediated arm (CD8+ cells lose IL-2 licensing). One cell type lost; both arms collapse. |
| 6 | AO3.2a | Concludes that the T helper is the central regulator — adaptive immunity is hub-and-spoke, not parallel-redundant, which is why a single CD4+ deficit (HIV, CD40L hyper-IgM syndrome) is catastrophic where a CD8+ deficit is not. |
Total: 6 marks (AO1 = 2, AO2 = 2, AO3 = 2). Specimen question modelled on the Edexcel 9BI0 paper format. Edexcel rewards candidates who use HIV not just as a stock example but as the evidence for T-helper centrality — the disease demonstrates the architecture.
Subscribe to continue reading
Get full access to this lesson and all 10 lessons in this course.